Strain-specific induction of murine lung tumors following in utero exposure to 3-methylcholanthrene

Molecular Carcinogenesis

Volumn 45, Issue 9, 2006, Pages 676-684

  Jennings Gee, Jamie E ^a   Moore, Joseph E ^a   Xu, Mian ^a,b   Dance, Stephanie T ^a   Kock, Nancy D ^a   McCoy, Thomas P ^a   Carr, J Jeffrey ^a   Miller, Mark Steven ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

CT imaging; Ki ras; Lung cancer; Transplacental carcinogenesis

Indexed keywords

3 METHYLCHOLANTHRENE; ARGININE; ASPARTIC ACID; CARCINOGEN; VALINE;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RESISTANCE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FETUS; FETUS DEVELOPMENT; GENE MUTATION; HEREDITY; IN VIVO STUDY; INCIDENCE; KI RAS GENE; LUNG CANCER; LUNG CARCINOGENESIS; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; ONCOGENE; PLACENTA; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGENY;

ANIMALS; FEMALE; FETAL DEVELOPMENT; FETUS; GENES, RAS; INBREEDING; LUNG NEOPLASMS; METHYLCHOLANTHRENE; MICE; PRENATAL INJURIES; TOMOGRAPHY, X-RAY COMPUTED; UTERUS;

MURINAE;

EID: 33748778455     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20215     Document Type: Article

References (27)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
2. Anderson LM, Diwan BA, Fear NT, Roman E. Critical windows of exposure for children's health: Cancer in human epidemiological studies and neoplasms in experimental animal models. Environ Health Perspect 2000;108:573-594.
3. Miller MS. Transplacental lung carcinogenesis: Molecular mechanisms and pathogenesis. Toxicol Appl Pharmacol 2004;198:95-110.
4. Rice JM. Perinatal period and pregnancy: Intervals of high risk for chemical carcinogens. Environ Health Perspect 1979;29: 23-27.
5. Malkinson AM. Molecular comparison of human and mouse pulmonary adenocarcinomas. Exp Lung Res 1998;24:541-555.
6. Malkinson AM. Inheritance of pulmonary adenoma susceptibility in mice. Prog Exp Tumor Res 1999;35:78-94.
7. Dragani TA, Manenti G, Pierotti MA. Genetics of murine lung tumors. Adv Cancer Res 1995;67:83-112.
8. Malkinson AM. The genetic basis of susceptibility to lung tumors in mice. Toxicology 1989;54:241-271 (published erratum appears in Toxicology 1989;55:349).
9. Witschi H. Modulation of lung tumor development in rats, hamsters and mice. Prog Exp Tumor Res 1991;33:132-153.
10. Gielen JE, Goujon FM, Nebert DW. Genetic regulation of aryl hydrocarbon hydroxylase induction. II. Simple Mendelian expression in mouse tissues in vivo. J Biol Chem 1972;247:1125-1137.
11. Thomas PE, Kouri RE, Hutton JJ. The genetics of aryl hydrocarbon hydroxylase induction in mice: A single gene difference between C57BL-6J and DBA-2J. Biochem Genet 1972;6:157-168.
12. Miller MS, Jones AB, Chauhan DP, Park SS, Anderson LM. Differential induction of fetal mouse liver and lung cytochromes P-450 by beta-naphthoflavone and 3-methylcholanthrene. Carcinogenesis 1989;10:875-891.
13. Miller MS, Jones AB, Park SS, Anderson LM. The formation of 3-methylcholanthrene-initiated lung tumors correlates with induction of cytochrome P450IA1 by the carcinogen in fetal but not adult mice. Toxicol Appl Pharmacol 1990;104:235-245.
14. Miller MS, Jones AB, Chauhan DP, Anderson LM. Role of the maternal environment in determining susceptibility to transplacentally induced chemical Carcinogenesis in mouse fetuses. Carcinogenesis 1990;11:1979-1984.
15. Wessner LL, Fan M, Schaeffer DO, McEntee MF, Miller MS. Mouse lung tumors exhibit specific Ki-ras mutations following transplacental exposure to 3-methylcholanthrene. Carcinogenesis 1996;17:1519-1526.
16. Leone-Kabler SL, Wessner LL, McEntee MF, D'Agostino RB, Miller MS. Ki-ras mutations are an early event and correlate with tumor stage in transplacentally-induced murine lung tumors. Carcinogenesis 1997;18:1163-1168.
17. Gressani KM, Leone-Kabler SL, O'Sullivan MG, Case LD, Malkinson AM, Miller MS. Strain-specific lung tumor formation in mice transplacentally exposed to 3-methylcholanthrene and post-natally exposed to butylated hydroxytoluene. Carcinogenesis 1999;20:2159-2165.
18. Miller MS, Gressani KM, Leone-Kabler S, Townsend AJ, Malkinson AM, O'Sullivan MG. Differential sensitivity to lung tumorigenesis following transplacental exposure of mice to polycydic hydrocarbons, heterocydic amines, and lung tumor promoters. Exp Lung Res 2000;26:709-730.
19. Xu M, Nelson GB, Moore JE, et al. Induction of Cyp1a1 and Cyp1b1 and formation of DNA adducts in C57BL/6, BALB/c, and F1 mice following in utero exposure to 3-methylcholanthrene. Toxicol Appl Pharmacol 2005;209:28-38.
20. Nikitin AY, Alcaraz A, Anver MR, et al. Classification of proliferative pulmonary lesions of the mouse: Recommendations of the mouse models of human cancers consortium. Cancer Res 2004;64:2307-2316.
21. Ryan J, Barker PE, Nesbitt MN, Ruddle FH. KRAS2 as a genetic marker for lung tumor susceptibility in inbred mice. J Natl Cancer Inst 1987;79:1351-1357.
22. You M, Wang Y, Stoner G, et al. Parental bias of Ki-ras oncogenes detected in lung tumors from mouse hybrids. Proc Natl Acad Sci USA 1992;89:5804-5808.
23. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6:65-70.
24. Carey V, Zeger SL, Diggle P. Modelling multivariate binary data with alternating logistic regressions. Biometrika 1993;80:517-526.
25. Chen B, Johanson L, Wiest JS, Anderson MW, You M. The second intron of the K-ras gene contains regulatory elements associated with mouse lung tumor susceptibility. Proc Natl Acad Sci USA 1994;91:1589-1593.
26. Massey TE, Devereux TR, Maronpot RR, Foley JF, Anderson MW. High frequency of K-ras mutations in spontaneous and vinyl carbamate-induced lung tumors of relatively resistant B6CF1 (C57BL/6J x BALB/d) mice. Carcinogenesis 1995;16:1065-1069.
27. Herzog CR, You M. Sequence variation and chromosomal mapping of the murine Cdkn2a tumor suppressor gene. Mamm Genome 1997;8:65-66.